PIP3-binding Proteins Promote Age-dependent Protein Aggregation and Limit Survival in C. Elegans
Overview
Authors
Affiliations
Class-I phosphatidylinositol 3-kinase (PI3KI) converts phosphatidylinositol 4,5-bisphosphate (PIP2) to phosphatidylinositol 3,4,5-triphosphate (PIP3). PIP3 comprises two fatty-acid chains that embed in lipid-bilayer membranes, joined by glycerol to inositol triphosphate. Proteins with domains that specifically bind that head-group (e.g. pleckstrin-homology [PH] domains) are thus tethered to the inner plasma-membrane surface where they have an enhanced likelihood of interaction with other PIP3-bound proteins, in particular other components of their signaling pathways. Null alleles of the C. elegans age-1 gene, encoding the catalytic subunit of PI3KI, lack any detectable class-I PI3K activity and so cannot form PIP3. These mutant worms survive almost 10-fold longer than the longest-lived normal control, and are highly resistant to a variety of stresses including oxidative and electrophilic challenges. Traits associated with age-1 mutation are widely believed to be mediated through AKT-1, which requires PIP3 for both tethering and activation. Active AKT complex phosphorylates and thereby inactivates the DAF-16/FOXO transcription factor. However, extensive evidence indicates that pleiotropic effects of age-1-null mutations, including extreme longevity, cannot be explained by insulin like-receptor/AKT/FOXO signaling alone, suggesting involvement of other PIP3-binding proteins. We used ligand-affinity capture to identify membrane-bound proteins downstream of PI3KI that preferentially bind PIP3. Computer modeling supports a subset of candidate proteins predicted to directly bind PIP3 in preference to PIP2, and functional testing by RNAi knockdown confirmed candidates that partially mediate the stress-survival, aggregation-reducing and longevity benefits of PI3KI disruption. PIP3-specific candidate sets are highly enriched for proteins previously reported to affect translation, stress responses, lifespan, proteostasis, and lipid transport.
Balasubramaniam M, Ganne A, Mainali N, Pahal S, Ayyadevara S, Shmookler Reis R iScience. 2024; 27(1):108745.
PMID: 38274404 PMC: 10809092. DOI: 10.1016/j.isci.2023.108745.
Kakraba S, Ayyadevara S, Mainali N, Balasubramaniam M, Bowroju S, Penthala N Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895969 PMC: 10610358. DOI: 10.3390/ph16101498.
Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease.
Ganne A, Balasubramaniam M, Griffin W, Shmookler Reis R, Ayyadevara S Pharmaceutics. 2022; 14(7).
PMID: 35890250 PMC: 9322874. DOI: 10.3390/pharmaceutics14071354.
Shmookler Reis R, Atluri R, Balasubramaniam M, Johnson J, Ganne A, Ayyadevara S Aging Cell. 2021; 20(5):e13326.
PMID: 33788386 PMC: 8135009. DOI: 10.1111/acel.13326.
The exosome-mediated PI3k/Akt/mTOR signaling pathway in cervical cancer.
Zhang W, Zhou Q, Wei Y, Da M, Zhang C, Zhong J Int J Clin Exp Pathol. 2020; 12(7):2474-2484.
PMID: 31934074 PMC: 6949546.